The Drug Hunter’s Assistant: Accelerating Drug Discovery With AI
Are The High Expectations Justified?
The hype around Artificial Intelligence has been deafening in recent years, but real progress can only come when drug discovery culture and regulators catch up with the technology.
You may also be interested in...
The South Korean AI-driven drug discovery venture is vying with global rivals in the space to show concrete validation of its approaches in partnered projects, while eyeing international expansion and new fundraising, its CEO says.
Focusing too much on the US provides a blinkered view of the industry and prevents access to the myriad opportunities on offer globally.
Immunogenicity data from Valneva’s COV-COMPARE study are encouraging, but the inactivated vaccine will need proper efficacy data to gain a toehold in a crowded market.